Skylight Health Group (NASDAQ:SLHG) Earns Outperform Rating from Analysts at Northland Securities

Stock analysts at Northland Securities began coverage on shares of Skylight Health Group (NASDAQ:SLHG) in a note issued to investors on Thursday, The Fly reports. The brokerage set an “outperform” rating on the stock.

A number of other research firms have also recently weighed in on SLHG. Echelon Wealth Partners reaffirmed a “buy” rating on shares of Skylight Health Group in a report on Monday, August 30th. Raymond James lowered their price target on shares of Skylight Health Group from C$9.00 to C$7.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 18th. Finally, Lake Street Capital initiated coverage on shares of Skylight Health Group in a research note on Monday, August 2nd. They set a “buy” rating and a $8.00 target price on the stock.

NASDAQ SLHG opened at $2.50 on Thursday. The business has a fifty day moving average of $2.92. The stock has a market capitalization of $97.22 million and a PE ratio of -13.16. Skylight Health Group has a 12-month low of $2.00 and a 12-month high of $6.25. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.36.

Skylight Health Group (NASDAQ:SLHG) last posted its quarterly earnings results on Monday, August 16th. The company reported ($0.09) earnings per share (EPS) for the quarter. Skylight Health Group had a negative return on equity of 57.94% and a negative net margin of 63.94%. The company had revenue of $8.56 million during the quarter.

Institutional investors have recently added to or reduced their stakes in the company. Virtu Financial LLC purchased a new stake in shares of Skylight Health Group in the 2nd quarter valued at approximately $58,000. Royal Bank of Canada purchased a new stake in Skylight Health Group during the 2nd quarter worth approximately $63,000. Finally, Citadel Advisors LLC purchased a new stake in Skylight Health Group during the 2nd quarter worth approximately $71,000. 0.20% of the stock is currently owned by institutional investors and hedge funds.

Skylight Health Group Company Profile

Skylight Health Group, Inc engages in the operation of a proprietary electronic health record system. It offers primary care, sub-specialty, allied health, laboratory and diagnostic testing, and subscription-based telemedicine service It operates through the United States and Canada segments. The company was founded by Pradyum Sekar and Kashaf Qureshi in 2014 and is headquartered in Mississauga, Canada.

Recommended Story: Intrinsic Value and Stock Selection

The Fly logo

Receive News & Ratings for Skylight Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skylight Health Group and related companies with MarketBeat.com's FREE daily email newsletter.